Genetic discoveries on Schizophrenia remain challenging. Traditional approaches have provided clues, but no genes. Novel theories that must account for extensive heterogeneity, including high discordance of monozygotic (MZD) twins, are needed. To this end, the extensive repeats of the human genome may provide the predisposition for DNA replication errors operational at every cell cycle during meiosis and mitosis. These errors will shower the genome with replication errors including copy number variations. Depending on the timing and the genes involved, this will contribute to the mutational load and disease. The evidence for such a mechanism in schizophrenia is emerging.
Schizophrenia is a complex mental disorder. It often destroys the lives of those who suffer from it, causes marked distress to their relatives, and owing to its remarkably high prevalence (1%), is a major financial burden to society. The recognition that genetic factors must play a crucial role in this common disease 1, 2 launched a search for its genes and genetic determinants. This search has relied on the genetic principles and methods that were found to be extraordinarily successful for single gene diseases. Results generated over the three decades from this research have yielded an assortment of candidate genes and genomic regions of interest. However, these results have not translated into the identification of any definitive schizophrenia causing gene(s). 3 The major reservation with these results is that they are infamously difficult to replicate. In fact, replication of the same markers, alleles and haplotypes in the majority of samples has remained elusive, 4 and the search for the genetic factors causing schizophrenia continues. [5] [6] [7] It represents one of the major challenges in medical sciences.
Most genetic research on schizophrenia is based on the observation that the disease risk increases with increasing genetic relatedness. 8 It supports the hypothesis that the disease may be caused by a set of common variant(s), each contributing a modest effect to the development of schizophrenia. 9 An extension to this model includes the common variant-multiple diseases hypothesis, 10 which recognizes that many disease genes may not be disease specific and common alleles of such genes may be a factor in related clinical phenotypes. 11, 12 It also argues that most variants will have a modest effect and that there are very few (if any) common susceptibility alleles of large effect in any of these disorders. Such a suggestion is compatible with the results of studies on candidate genes, linkage and association, which represent the main stream of this research. 13 Further, there is a realization that an ambitiously larger number (tens of thousands) of patients and controls will be needed to resolve concerns. These are logical approaches to the complications of genetic heterogeneity among relatives. At the same time, the difficulty in finding genes and genetic determinants responsible for schizophrenia demands a reconsideration of its genetic model, as well as a clearer disease definition. 14 Yet another common observation on the occurrence of schizophrenia is that monozygotic twins have a concordance rate of B46%.
8 Such observations are accommodated by the effect of environment 15, 16 and epigenetic mechanisms. [17] [18] [19] To this end, O'Reilly and Singh 20 suggested that a random genomic event (e.g., retroviral infection, transpositions) could be involved in schizophrenia. Specifically, it may account for the discordance of monozygotic (MZD) twins in schizophrenia. A comprehensive search for such events in schizophrenia MZD twins is in its infancy, 18, 21, 22 and no undeniable difference in such twins has been reported. However, any difference responsible for the discordant phenotype of MZD twins will represent a breakthrough in schizophrenia.
To this end, Guidry and Kent 23 hypothesized that, if the inheritance of a single recessive mutated allele of a gene crucial in brain development is followed by a somatic mutation in the normal allele during critical periods of brain development, this could result in developmental abnormalities that are expressed behaviorally as schizophrenia. The somatic mutation may not always occur, which could explain the MZD twins as well as variability of expression seen in the clinical population. This model will be radically different from the polygenetic-oligogenic model in which variant(s) have a small and cumulative effect.
The evidence is accumulating that at least one of the mutational mechanisms in schizophrenia may involve copy number variations (CNVs). If operational during mitosis, it may account for the MZD twins in schizophrenia. This proposition is based on two sets of results. The first is the report by Bruder et al., 24 who found that each of the 19 monozygotic twin pairs studied were different in CNVs. This follows Fraga et al., 25 who reported that monozygotic twins continue to acquire genomic differences during the lifetime. Such results argue that monozygotic cotwins that start from a single zygote acquire genetic and epigenetic differences during development, which may account for their discordance. 17 The second set of results show that patients with schizophrenia have a higher number of individually rare CNVs than the controls. Also, the CNVs in schizophrenia cases disproportionately disrupted genes controlling neurodevelopment that are usually affected in this disease. 26, 27 Further, Xu et al. found that rare de novo CNVs at many different loci were more frequent in sporadic cases of schizophrenia than in the unaffected controls. 28 Such results are followed by Stefansson et al.and Stone et al., 29, 30 who independently confirmed earlier findings and validated each other's observation of two new CNV loci, which occurred independently in multiple founders. The results suggest that multiple, rare, and recent individual specific CNVs, with major effects on genes from neurodevelopmental pathways, may cause schizophrenia. This suggestion also predicts that different patients may have different sets of genes affected, making assessment of CNVs for few candidate genes in schizophrenia ineffective. 31 Also, some of the genomic changes may be de novo with a somatic origin, resulting in cellular mosaics.
The question of what causes CNVs has not been investigated adequately. What is known is that certain human genomic regions are prone to recurrent CNVs formation and instability. They appear conserved in related primates and contain highly homologous intrachromosomal segmental duplications. 32 The implication of such a sequence feature is that they have the potential to undergo recombination and cause errors during DNA replication needed as a prerequisite for meiosis and mitosis. Unfortunately, despite being two of the oldest topics in molecular biology, the replication of DNA and segregation of chromosomes are not well understood. However, the result of the replication and segregation errors will be that all cells of an individual will not be identical. They will differ in de novo mutations and aberrations including CNVs, making every individual a mosaic. The evidence for genomic mosaics in the brain has been provided by Westra et al., 33 who showed that aneuploid cells are present in proliferating cerebellum in mice and humans. Although the frequency of such cells is not known, they vary from one brain region to another and may account for B20% of the cells. The aneuploid cells result from mitotic abnormalities making most brain regions, particularly neuronal and glial cells, genomically mosaics. In fact, aneuploidy (mosaicism) may be a general feature and normal component of central nervous system development and organization. Further, if genomic mosaicism is imperative in the central nervous system, it may result from a variety of mechanisms. One of those mechanisms may be copy number variation. Also, some of these may be generated somatically during growth and development. The occurrence of somatic de novo CNVs will be expected to predominate in genomic regions with duplications and repeated sequences. This is supported by Stefansson et al., 29 who found that 23 of the 66 novel CNVs were flanked by low copy repeats. Also, an assessment of the sequences around the CNVs sites in the Database of Genomic Variants on chromosome 22 suggests that these sites are prone to regions that are rich in repeats. Thus, the higher-order genome architecture is expected to be prone to errors of replication during every DNA replication cycle engendering CNVs. During meiosis, it will introduce new CNVs in the population whereas if it followed mitosis, it will generate genomic mosaics. This could explain genomic MZD twins. Depending on the genes involved it will account for the MZD twins for phenotypes and diseases affected by CNVs including schizophrenia.
The results argue that the human genome is not static. We do not simply acquire parental genomes and pass them on to the next generation, after recombination and rare mutations. Rather, the genome undergoes a variety of alterations at every DNA replication cycle, which follows cell division. One of these alterations may result from the semi-conservative replication of the DNA, particularly in repetitive (that are common and dispersed in the human genome) regions, resulting in CNVs showers across the genome. If operational at meiosis, this mechanism will result in gametes with CNVs differences. It will make up for any selective disadvantage and maintain a relatively high frequency of the disease. Further, any CNVs occurrence at mitosis will result in mosaic individuals making each patient including MZD twins different with respect to the genes and cell types affected. Finally, ongoing CNVs showers may vary across individuals, and depending on the number of genes affected and the physiological role they play, this could explain the involvement of this mechanism in a number of complex diseases. The evidence for involvement of CNVs in some mental disorders has begun to emerge led by autism 34 and schizophrenia. 26, 28 The CNVs showers model will account for their familial pattern, extensive heterogeneity and variability among patients, paternal age effect and the effect of environment. It merits experimental authentication using exceptional human brain samples including rare monozygotic twins discordant for schizophrenia.
